Repository logo
 
Publication

Effect of the pharmaceuticals metformin, escitalopram and furosemide in cyanobacteria growth

dc.contributor.authorOliveira, L.
dc.contributor.authorPereira, R.
dc.contributor.authorCosta, J.
dc.contributor.authorBarros, Piedade
dc.date.accessioned2024-05-17T08:53:56Z
dc.date.available2024-05-17T08:53:56Z
dc.date.issued2015-07
dc.description.abstractWorldwide one of the most prevalent water problems is eutrophication, a result of high nutrient concentration, mainly phosphorus and nitrogen. In freshwater environments, anthropogenic inputs of nutrients and other substances are a major contributing to eutrophication and consequent formation of cyanobacteria and algal blooms. The formation of cyanobacteria blooms can result in toxin production and have ecological and human health impacts. Another emerging water quality concern is the impact of personal care products and pharmaceuticals in the environment. In eutrophic waters the increased availability of pharmaceuticals can interfere with cyanobacteria cells and disrupt or enhance cyanobacteria growth. This study describes the effect of metformine, escitalopram and furosemide in the cyanobacteria Microcystis aeruginosa. Cyanobacteria tests were conducted following the European Guideline (OECD 201) for algal and cyanobacteria growth inhibition test. Cyanobacteria were incubated in microplate with pharmaceuticals solutions prepared in Z8 medium under continuous light and shaking at 22ºC. Results were quantified in terms of average growth rates calculated from cell numbers based on OD determination at 24h period until 120h. Pharmaceuticals used were metformin an anti-diabetic, escitalopram an antidepressive and furosemide a diuretic in ten concentrations. At 120h exposure and at the higher concentration tested the three pharmaceuticals (metformin-10mg/mL; 100% inhibition; escitalopram- 0.1mg/ml; 100% inhibition and furosemide-0.4 mg/mL; 50% inhibition) inhibited Microcystis growth rate. Escitalopram response showed hormesis but at higher concentrations it was more toxic than metformin and furosemide. Time related response was different between pharmaceuticals. The three pharmaceuticals interfere with Microcystis growth rate in different ways.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationOliveira, L., Pereira, R., Costa, J., & Barros, P. (2015). Effect of the pharmaceuticals metformin, escitalopram and furosemide in cyanobacteria growth. Livro de Resumos 4º Congresso Ibérico de Cianotoxinas VI Reunião da Rede Ibérica de Cianotoxinas, 62pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.22/25522
dc.language.isoengpt_PT
dc.publisherInstituto Nacional de Saúde Doutor Ricardo Jorgept_PT
dc.relation.publisherversionhttps://repositorio.insa.pt/bitstream/10400.18/3716/1/Livro-de-resumos-4%c2%baCIC2015.pdfpt_PT
dc.subjectMicrocystispt_PT
dc.subjectMetforminept_PT
dc.subjectEscitaloprampt_PT
dc.subjectFurosemidept_PT
dc.subjectHormesispt_PT
dc.titleEffect of the pharmaceuticals metformin, escitalopram and furosemide in cyanobacteria growthpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceLisboapt_PT
oaire.citation.startPage62pt_PT
oaire.citation.title4º Congresso Ibérico de Cianotoxinas VI Reunião da Rede Ibérica de Cianotoxinaspt_PT
person.familyNameGonçalves de Barros
person.givenNamePiedade Aurora
person.identifier.ciencia-idD210-6003-454B
person.identifier.orcid0000-0002-2635-251X
person.identifier.scopus-author-id23981959400
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublicationa85b368a-8f13-45eb-a744-7c5810a38e2c
relation.isAuthorOfPublication.latestForDiscoverya85b368a-8f13-45eb-a744-7c5810a38e2c

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
COM_Piedade Barros.pdf
Size:
59.76 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: